L1210 |
ED50 |
= |
0.7 |
uM |
In vitro inhibition against replication of L1210 murine cells |
CHEMBL1122407 |
Sarcoma-180 |
ED50 |
= |
4.0 |
uM |
In vitro inhibition against replication of Sarcoma-80 cells |
CHEMBL1122407 |
Thymidine kinase, cytosolic |
Activity |
= |
77.0 |
% |
Inhibitory activity against thymidine kinase (TK) from L1210 cells |
CHEMBL1122407 |
Thymidine kinase, cytosolic |
Activity |
= |
84.0 |
% |
Inhibitory activity against thymidine kinase (TK) from L1210 cells |
CHEMBL1122407 |
Deoxycytidine kinase |
Activity |
= |
89.0 |
% |
Inhibitory activity against deoxycytidine kinase from L1210 cells |
CHEMBL1122407 |
Deoxycytidine kinase |
Activity |
= |
85.0 |
% |
Inhibitory activity against deoxycytidine kinase from L1210 cells |
CHEMBL1122407 |
L1210 |
Inhibition |
< |
5.0 |
% |
Compound was tested for the inhibition of the transport of aminoisobutyric acid into L1210 cells at the 10 uM concentration after <20 min |
CHEMBL1123175 |
L1210 |
Inhibition |
< |
5.0 |
% |
Compound was tested for the inhibition of the transport of methionine into L1210 cells at the 10 uM concentration after <20 min |
CHEMBL1123175 |
unidentified adenovirus |
ED50 |
> |
100.0 |
uM |
In vitro antiviral activity against adeno virus using plaque reduction assay. |
CHEMBL1122236 |
Staphylococcus aureus |
MIC |
> |
400000.0 |
nM |
In vitro minimum inhibitory concentration against Staphylococcus aureus |
CHEMBL1122236 |
D-38 |
ED50 |
= |
3.0 |
uM |
In vitro cytotoxicity against human D-38 cells. |
CHEMBL1122236 |
L cells |
ED50 |
= |
1.0 |
uM |
in vitro cytotoxicity against mouse L cells. |
CHEMBL1122236 |
Vibrio cholerae |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Vibrio cholerae |
CHEMBL1122236 |
Pasteurella multocida |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Pasteurella multocida |
CHEMBL1122236 |
Salmonella typhimurium |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Salmonella Typhimurium |
CHEMBL1122236 |
Salmonella |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Salmonella typhi |
CHEMBL1122236 |
Shigella flexneri |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Shigella flexneri |
CHEMBL1122236 |
Escherichia coli |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Escherichia coli |
CHEMBL1122236 |
Serratia marcescens |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Serratia marcescens |
CHEMBL1122236 |
Klebsiella pneumoniae |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Klebsiella pneumoniae |
CHEMBL1122236 |
Klebsiella aerogenes |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Enterobacter aerogenes |
CHEMBL1122236 |
Citrobacter freundii |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Citrobacter freundii |
CHEMBL1122236 |
Proteus vulgaris |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Proteus vulgaris |
CHEMBL1122236 |
Proteus mirabilis |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Proteus mirabilis |
CHEMBL1122236 |
Pseudomonas aeruginosa |
MIC |
> |
200000.0 |
nM |
Minimum inhibitory concentration against Pseudomonas aeruginosa |
CHEMBL1122236 |
L1210 |
ID50 |
= |
0.7 |
uM |
Ability to effect the replication of L1210 cells in vitro |
CHEMBL1122361 |
NON-PROTEIN TARGET |
ID50 |
= |
4.0 |
uM |
Ability to effect the replication of S-180 cells in vitro |
CHEMBL1122361 |
Mus musculus |
T/C |
= |
283.0 |
% |
Ratio of treated to that of control was determined in mice tested in vivo(on day 31) |
CHEMBL1122361 |